Research programme: DepoVax-based malaria vaccine - Immunovaccine/University of Edinburgh
Latest Information Update: 07 Jun 2016
At a glance
- Originator University of Edinburgh
- Developer Immunovaccine; University of Edinburgh
- Class Antiparasitics
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Malaria